Company intelligence / Profile preview

Burlington Bio

Burlington, Vermont, USAburlington.bio ↗

Ownership: Private
Employees: ~7
Development stage: Other

Overview

Burlington Bio develops hydrogel scaffolds made from whey protein and seaweed to support the growth of lab-grown/cultivated meat. The company leverages waste valorization—turning agricultural byproducts into valuable food ingredients—and aims to either license its scaffold protocol or manufacture the material at scale for cultivated meat producers. Early-stage startup with initial venture backing, currently refining its core product in preparation for broader commercialization.

Modalities: Hydrogel scaffoldMicrocarrier (for cellular agriculture)Protein-based biomaterial
Industry: Non-Drug Biotech

Partnerships

BioLabs Innovation Center at University of Vermont/BioInnovation LabsHula Venture Capital FundAbele Ventures

Beyond the preview

Go deeper on Burlington Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Burlington Bio.

Explore the full profile